Thermo Fisher Scientific Inc.
multinational company providing scientific instrumentation
TMO NYSE
ISIN US8835561023 SEC CIK 97745 LEI HCHV7422L5HDJZCRFL38
Follow Thermo Fisher Scientific
Weekly email: filings, results
Revenue, last quarter
$12.1B
+9.1% vs same quarter last year
Net income
$1.7B
+6.5% vs same quarter last year
EPS, diluted
$4.64
+8.7% vs same quarter last year
Operating cash flow
$2.6B
+13.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $44.6B | $6.7B |
| FY24 | $42.9B | $6.3B |
| FY23 | $42.9B | $6B |
| FY22 | $44.9B | $7B |
| FY21 | $39.2B | $7.7B |
| FY20 | $32.2B | $6.4B |
| FY19 | $25.5B | $3.7B |
| FY18 | $24.4B | $2.9B |
| FY17 | $20.9B | $2.2B |
| FY16 | $18.3B | $2B |
| FY15 | $17B | $2B |
| FY14 | $16.9B | $1.9B |
| FY13 | $13.1B | $1.3B |
| FY12 | $12.5B | $1.2B |
| FY11 | $11.6B | $1.3B |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | 17.4% | 15.1% |
| FY24 | - | 17.1% | 14.8% |
| FY23 | - | 16% | 13.9% |
| FY22 | - | 18.7% | 15.5% |
| FY21 | - | 25.6% | 19.7% |
| FY20 | - | 24.2% | 19.8% |
| FY19 | - | 18% | 14.5% |
| FY18 | - | 15.5% | 12.1% |
| FY17 | 57.1% | 14.2% | 10.6% |
| FY16 | 55.1% | 13.5% | 11.1% |
| FY15 | 55.3% | 13.8% | 11.6% |
| FY14 | 53% | 14.8% | 11.2% |
| FY13 | 51.8% | 12.3% | 9.7% |
| FY12 | 51.2% | 11.8% | 9.4% |
| FY11 | 50.4% | 10.8% | 11.5% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $6.3B |
| FY24 | $7.3B |
| FY23 | $6.9B |
| FY22 | $6.9B |
| FY21 | $6.8B |
| FY20 | $6.8B |
| FY19 | $4B |
| FY18 | $3.8B |
| FY17 | $3.5B |
| FY16 | $2.8B |
| FY15 | $2.5B |
| FY14 | $2.3B |
| FY13 | $1.7B |
| FY12 | $1.7B |
| FY11 | $1.4B |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $636M | $3B |
| FY24 | $583M | $4B |
| FY23 | $523M | $3B |
| FY22 | $455M | $3B |
| FY21 | $395M | $2B |
| FY20 | $337M | $1.5B |
| FY19 | $297M | $1.5B |
| FY18 | $266M | $500M |
| FY17 | $237M | $750M |
| FY16 | $238M | $1.3B |
| FY15 | $241M | $500M |
| FY14 | $234.8M | $0 |
| FY13 | $216.2M | $89.8M |
| FY12 | $142.2M | $1.2B |
| FY11 | $0 | $1.3B |
- Thermo Fisher Scientific
- Technology median
Show the numbers
| Year | Thermo Fisher Scientific | Technology median |
|---|---|---|
| FY25 | 15.1% | −2.3% |
| FY24 | 14.8% | −5% |
| FY23 | 13.9% | −6.7% |
| FY22 | 15.5% | −4.4% |
| FY21 | 19.7% | −1.7% |
| FY20 | 19.8% | −3% |
| FY19 | 14.5% | 0% |
| FY18 | 12.1% | 0.8% |
| FY17 | 10.6% | 2% |
| FY16 | 11.1% | 2.3% |
| FY15 | 11.6% | 3.1% |
| FY14 | 11.2% | 2.9% |
| FY13 | 9.7% | 3.9% |
| FY12 | 9.4% | 3.9% |
| FY11 | 11.5% | 5.7% |